Abstract
Cotton-top tamarins (CTTs) with histologically confirmed persistent and active colitis were given the leukotriene B4 (LTB4) receptor antagonist, SC-41930, (10 mg/kg BW, by gavage b.i.d.) for eight weeks. Anti-inflammatory activity was evaluated by colonic biopsy, stool consistency and the level of the lipid mediators LTB4 and prostaglandin E2 (PGE2) in rectal dialysates. Stool consistency did not improve with treatment but did not worsen. Blood chemistry (ALT, AST, LDH) and hematological parameters neither showed any untoward effects of SC-41930 treatment nor was there any effect on body weight. In rectal dialysate LTB4 levels were significantly reduced from pretreatment level of 4.87±1.46 ng/ml to 1.07±0.67 and 2.45±0.13 ng/ml at 4 and 8 weeks, respectively, and higher prostaglandin E2 (PGE2) over time. Histologically, 5/7 improved, 1/7 remained the same and 1/7 worsened.
Oral SC-41930 treatment was safe and associated with an anti-colitic effect. The reduced LTB4 levels (affecting granulocyte degranulation and recruitment into tissues) and increased PGE2 (perhaps exerting a mucosal protective effect) may, in part explain the observed efficacy of this compound in active tamarin colitis. Use of the CTT model could provide insight into the inflammatory mediator contribution to idiopathic colitis and serve as a useful bridge between preclinical pharmacology and the assessment of these compounds in the medical management of human inflammatory bowel disease.
Similar content being viewed by others
References
N. K. Clapp, M. A. Henke, R. M. Hansard, R. L. Carson, L. J. Adams and R. V. Nardi,Natural history, time course, and pathogenesis of idiopathic colitis in cotton-top tamarins. InA Primate Model for the Study of Colitis and Colonic Carcinoma. (Ed. N. K. Clapp) pp. 83–100, CRC Press, Boca Raton 1993.
D. Fretland, D. Widomski, B. Tsai, J. Zemaitis, S. Levin, S. Djuric, R. Shone and T. Gaginella,Effect of the leukotriene B 4 receptor antagonist SC-41930 on colonic inflammation in the rat, guinea pig and rabbit. J. Pharmacol. Exp. Therap.255, 572–576 (1990).
S. Djuric, D. Fretland and T. Penning,The leukotriene B 4 receptor antagonists. Drug Future17, 819–830 (1992).
N. Clapp, M. Henke, R. Hansard and R. Carson,A protocol to evaluate the efficacy of anticolitic agents against ulcerative colitis in cotton-top tamarins. InA Primate Model for the Study of Colitis and Colonic Carcinoma. (Ed. N. K. Clapp) pp. 133–143, CRC Press, Boca raton 1993.
P. Sharon and W. Stenson,Enhanced synthesis of leukotriene B 4 by colonic mucosa in inflammatory bowel disease. Gastroenterol.86, 453–460 (1984).
D. Fretland, D. Widomski, C. Anglin, R. Walsh, S. Levin, T. A. Gasiecki and P. Collins,Mucosal protective activity of prostaglandin analogs in rodent colonic inflammation. Inflammation16, 623–629 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clapp, N., Henke, M., Hansard, R. et al. Anti-inflammatory activity of the leukotriene B4 receptor antagonist, SC-41930, in colitic cotton-top tamarins. Agents and Actions 41 (Suppl 2), C254–C255 (1994). https://doi.org/10.1007/BF01987659
Issue Date:
DOI: https://doi.org/10.1007/BF01987659